Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis-Reference-Cited by-同舟云学术

Minimal residual disease detectable by quantitative assessment of WT1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis

Published:2012-12-12 Issue:1 Volume:27 Page:E21-E29
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Válková Veronika,Polák Jaroslav¹,Marková Marketa,Vítek Antonin,Hájková Hana¹,Šálek Cyril,Procházka Bohumil²,Cetkovský Petr,Trněný Marek

Affiliation:

1. Department of Molecular Biology; Institute of Haematology and Blood Transfusion; Prague; Czech Rep

2. Department of Biostatistics; University Hospital; Third Faculty of Medicine; Charles University; Prague; Czech Rep

Publisher

Wiley

Subject

Transplantation

Reference30 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood,2010

2. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood,2010

3. Cytogenetics in acute leukemia;Mrozek;Blood Rev,2004

4. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia;Buccisano;Blood,2012

5. Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia;Corbacioglu;J Clin Oncol,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WT1 and TP53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia;Molecular Biology Reports;2024-02-01

2. Wilms tumor 1 gene expression in acute myeloid leukemia: prognostic significance and usefulness in minimal residual disease monitoring—a case–control study;Egyptian Journal of Medical Human Genetics;2022-08-01

3. Prognostic Significance of WT1 Expression Level Thershold in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation: Meta-Analysis;2022-04-19

4. WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML – A Single-center 14-year Experience;Clinical Lymphoma Myeloma and Leukemia;2021-02

5. WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia;Clinical Lymphoma Myeloma and Leukemia;2020-12